1.7 ML teclistamab-cqyv 90 MG/ML Injection [Tecvayli]

RxCUI
2619444
RxNorm name
1.7 ML teclistamab-cqyv 90 MG/ML Injection [Tecvayli]
Display name
1.7 ML teclistamab-cqyv 90 MG/ML Injection [Tecvayli]
Full name
1.7 ML teclistamab-cqyv 90 MG/ML Injection [Tecvayli]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:59

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761291Tecvayliteclistamab-cqyv351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
54e0f974-ccee-44ea-9254-40e9883cee1eTECVAYLI 153 MG in 1.7 ML Injection [PSN] · 1.7 ML teclistamab-cqyv 90 MG/ML Injection [Tecvayli] [SBD] · 1.7 ML Tecvayli 90 MG/ML Injection [SY] · Tecvayli 153 MG per 1.7 ML Injection [SY]416These highlights do not include all the information needed to use TECVAYLI safely and effectively. See full prescribing information for TECVAYLI. TECVAYLI ® (teclistamab-cqyv) injection, for subcutaneous use Initial U.S. Approval: 202220260310